Person:
Perry, George

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Perry

First Name

George

Name

Perry, George

Filters

20001

Settings

Author's Publications: search.filters.isAuthorOfPublication.0a124851-49f1-4447-87b3-5761bfe0e045

Search Results

Now showing 1 - 1 of 1
  • No Thumbnail Available
    Publication
    Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc
    (American Society for Biochemistry & Molecular Biology (ASBMB), 2000-05-08) Cuajungco, Math P.; Goldstein, Lee E.; Nunomura, Akihiko; Smith, Mark A.; Lim, James T.; Atwood, Craig S.; Huang, Xudong; Farrag, Yasser W.; Perry, George; Bush, Ashley I.
    Abeta binds Zn(2+), Cu(2+), and Fe(3+) in vitro, and these metals are markedly elevated in the neocortex and especially enriched in amyloid plaque deposits of individuals with Alzheimer's disease (AD). Zn(2+) precipitates Abeta in vitro, and Cu(2+) interaction with Abeta promotes its neurotoxicity, correlating with metal reduction and the cell-free generation of H(2)O(2) (Abeta1-42 > Abeta1-40 > ratAbeta1-40). Because Zn(2+) is redox-inert, we studied the possibility that it may play an inhibitory role in H(2)O(2)-mediated Abeta toxicity. In competition to the cytotoxic potentiation caused by coincubation with Cu(2+), Zn(2+) rescued primary cortical and human embryonic kidney 293 cells that were exposed to Abeta1-42, correlating with the effect of Zn(2+) in suppressing Cu(2+)-dependent H(2)O(2) formation from Abeta1-42. Since plaques contain exceptionally high concentrations of Zn(2+), we examined the relationship between oxidation (8-OH guanosine) levels in AD-affected tissue and histological amyloid burden and found a significant negative correlation. These data suggest a protective role for Zn(2+) in AD, where plaques form as the result of a more robust Zn(2+) antioxidant response to the underlying oxidative attack.